These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6788545)

  • 1. Kinetic studies of three different molecular forms of urokinase for the activation of native human plasminogen.
    Toki N; Takasugi S; Sumi H
    Enzyme; 1981; 26(4):221-4. PubMed ID: 6788545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.
    Paoni NF; Castellino FJ
    J Biol Chem; 1979 Mar; 254(6):2064-70. PubMed ID: 154519
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the high-affinity interaction between human plasminogen and pro-urokinase.
    Lijnen HR; Zamarron C; Collen D
    Eur J Biochem; 1985 Jul; 150(1):141-4. PubMed ID: 3926492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation.
    Lenich C; Pannell R; Gurewich V
    Thromb Res; 1991 Oct; 64(1):69-80. PubMed ID: 1776140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fibrinogen and fibrin on the activation of Glu- and Lys-plasminogen by urokinase.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1984 Mar; 33(6):561-9. PubMed ID: 6539003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1984 Nov; 144(3):541-4. PubMed ID: 6489341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasminogen activator and esterase activities of the two forms of urokinase.
    Ong EB; Soberano ME; Johnson AJ; Dharmgrongartama ED
    Thromb Res; 1981 Nov; 24(3):223-32. PubMed ID: 7038974
    [No Abstract]   [Full Text] [Related]  

  • 11. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
    Thorsen S
    Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic analysis of covalent hybrid plasminogen activators: effect of CNBr-degraded fibrinogen on kinetic parameters of Glu1-plasminogen activation.
    Lee PP; Wohl RC; Boreisha IG; Robbins KC
    Biochemistry; 1988 Sep; 27(19):7506-13. PubMed ID: 2974723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasmin.
    Christensen U; Müllertz S
    Biochim Biophys Acta; 1977 Jan; 480(1):275-81. PubMed ID: 137749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).
    Fears R; Dodd I; Ferres H; Robinson JH
    Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator.
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1988 Jan; 49(2):253-63. PubMed ID: 3129817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.